Title |
Antiplatelet therapy for acute ischaemic stroke
|
---|---|
Published by |
John Wiley & Sons, Ltd, July 2008
|
DOI | 10.1002/14651858.cd000029.pub2 |
Pubmed ID | |
Authors |
Sandercock, Peter AG, Counsell, Carl, Gubitz, Gordon J, Tseng, Mei-Chiun |
Abstract |
In patients with acute ischaemic stroke, platelets become activated. Antiplatelet therapy might reduce the volume of brain damaged by ischaemia and reduce the risk of early recurrent ischaemic stroke. This might reduce the risk of early death and improve long-term outcome in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial haemorrhage. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Japan | 1 | 1% |
United States | 1 | 1% |
Canada | 1 | 1% |
Unknown | 86 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 18% |
Student > Bachelor | 10 | 11% |
Student > Master | 9 | 10% |
Student > Ph. D. Student | 7 | 8% |
Student > Doctoral Student | 7 | 8% |
Other | 24 | 26% |
Unknown | 18 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 46% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
Neuroscience | 6 | 7% |
Nursing and Health Professions | 5 | 5% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Other | 3 | 3% |
Unknown | 25 | 27% |